• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多药耐药性MCF-7细胞中蛋白激酶C(PKC)同工酶表达的选择性调控。PKCα表达增强的功能意义。

Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha.

作者信息

Blobe G C, Sachs C W, Khan W A, Fabbro D, Stabel S, Wetsel W C, Obeid L M, Fine R L, Hannun Y A

机构信息

Department of Medicine, Duke University, Durham, North Carolina.

出版信息

J Biol Chem. 1993 Jan 5;268(1):658-64.

PMID:8093247
Abstract

The multidrug resistance (MDR) phenotype induces cross-resistance to many chemotherapeutic agents in cancer cells. Protein kinase C (PKC) has been implicated in the regulation of the MDR phenotype. In order to determine the role of specific PKC isoenzymes in regulating the MDR phenotype, the expression and activity of PKC isoenzymes in the human breast cancer cell line, MCF-7-WT, and an MDR subline, MCF-7-MDR, were examined. The MDR phenotype was associated with a 10-fold increase in calcium-dependent PKC activity as well as a 10-fold decrease in calcium-independent activity was due to a selective increase in the activity was due to a selective increase in the expression of PKC alpha as determined by Western blot analysis and hydroxylapatite chromatography. This increase in expression of PKC alpha was regulated at the message level as demonstrated by Northern blot analysis. The decrease in calcium-independent activity was caused by a decrease in the expression of PCK delta and epsilon. The significance of the increase in PKC alpha expression was then demonstrated by a commensurate 11-fold increase in the basal and stimulated phosphorylation of the myristolated alanine-rich C kinase substrate. Phosphorylation of P-glycoprotein, the cellular mediator of the MDR phenotype, was increased > 20-fold in the unstimulated MCF-7-MDR cell line and its phosphorylation was further increased 2-fold in response to phorbol 12-myristate 13-acetate. These changes paralleled the increases in P-glycoprotein pump function and the MDR phenotype underscoring the role for PKC alpha in regulating P-glycoprotein phosphorylation and function.

摘要

多药耐药(MDR)表型可诱导癌细胞对多种化疗药物产生交叉耐药。蛋白激酶C(PKC)与MDR表型的调控有关。为了确定特定PKC同工酶在调控MDR表型中的作用,研究了人乳腺癌细胞系MCF-7-WT及其MDR亚系MCF-7-MDR中PKC同工酶的表达和活性。MDR表型与钙依赖性PKC活性增加10倍以及非钙依赖性活性降低10倍相关,非钙依赖性活性降低是由于PKCα表达选择性增加所致,这通过蛋白质印迹分析和羟基磷灰石色谱法得以确定。如Northern印迹分析所示,PKCα表达的这种增加在转录水平受到调控。非钙依赖性活性的降低是由PCKδ和ε表达的减少引起的。然后,通过富含丙氨酸的肉豆蔻酰化C激酶底物的基础磷酸化和刺激后磷酸化相应增加11倍,证明了PKCα表达增加的重要性。在未刺激的MCF-7-MDR细胞系中,MDR表型的细胞介质P-糖蛋白的磷酸化增加了20倍以上,并且在佛波醇12-肉豆蔻酸酯13-乙酸酯刺激下,其磷酸化进一步增加了2倍。这些变化与P-糖蛋白泵功能的增加以及MDR表型平行,突出了PKCα在调节P-糖蛋白磷酸化和功能中的作用。

相似文献

1
Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha.多药耐药性MCF-7细胞中蛋白激酶C(PKC)同工酶表达的选择性调控。PKCα表达增强的功能意义。
J Biol Chem. 1993 Jan 5;268(1):658-64.
2
Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism.N-肉豆蔻酰化蛋白激酶C-α(PKC-α)假底物肽通过一种不依赖P-糖蛋白的机制有效诱导人结肠癌细胞摄取化疗药物。
Invest New Drugs. 1997;15(4):311-8. doi: 10.1023/a:1005933401603.
3
Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha.蛋白激酶C(PKC)同工酶在药物敏感和多药耐药KB细胞中的表达、亚细胞分布及对佛波酯的反应:PKC-α调节改变的证据
Eur J Biochem. 1996 Aug 1;239(3):796-804. doi: 10.1111/j.1432-1033.1996.0796u.x.
4
An N-myristoylated protein kinase C-alpha pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate.一种在人乳腺癌细胞中作为多药耐药逆转剂发挥作用的N-肉豆蔻酰化蛋白激酶C-α假底物肽不是P-糖蛋白底物。
Cancer Chemother Pharmacol. 1997;40(5):453-6. doi: 10.1007/s002800050686.
5
Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance.
Cancer Commun. 1989;1(5):285-92. doi: 10.3727/095535489820874922.
6
Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide.一种N-肉豆蔻酰化蛋白激酶C-α假底物肽对人乳腺癌细胞多药耐药性的部分逆转作用
J Biol Chem. 1996 Jan 26;271(4):2102-11. doi: 10.1074/jbc.271.4.2102.
7
Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein.通过对冈田酸(一种蛋白磷酸酶抑制剂)产生抗性筛选出的人白血病K562细胞突变体(K562/OA200)缺乏蛋白激酶C-ε,表现出多药耐药表型,并表达药物转运蛋白P-糖蛋白。
J Biol Chem. 1994 Apr 22;269(16):12332-8.
8
Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.沙芬戈对多药耐药性的部分抑制作用与P-糖蛋白底物活性的调节无关,而与蛋白激酶C的抑制作用相关。
J Biol Chem. 1995 Nov 3;270(44):26639-48. doi: 10.1074/jbc.270.44.26639.
9
Identification and functional characterization of protein kinase C isozymes in platelets and HEL cells.
J Biol Chem. 1992 May 15;267(14):10011-7.
10
Selective inhibition of the effects of phorbol ester on doxorubicin resistance and P-glycoprotein by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H7) in multidrug-resistant MCF-7/Dox human breast carcinoma cells.蛋白激酶C抑制剂1-(5-异喹啉磺酰基)-2-甲基哌嗪(H7)对多药耐药性MCF-7/Dox人乳腺癌细胞中佛波酯对阿霉素耐药性和P-糖蛋白作用的选择性抑制
Biochem Pharmacol. 1996 Aug 9;52(3):393-9. doi: 10.1016/0006-2952(96)00240-7.

引用本文的文献

1
Modulation of redox homeostasis: A strategy to overcome cancer drug resistance.氧化还原稳态的调节:一种克服癌症耐药性的策略。
Front Pharmacol. 2023 Mar 22;14:1156538. doi: 10.3389/fphar.2023.1156538. eCollection 2023.
2
Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells in vitro.体外鉴定两种在结直肠癌细胞中与低剂量过氧化氢具有协同毒性的激酶抑制剂。
Cancers (Basel). 2020 Jan 2;12(1):122. doi: 10.3390/cancers12010122.
3
Obesity-Altered Adipose Stem Cells Promote ER⁺ Breast Cancer Metastasis through Estrogen Independent Pathways.
肥胖改变的脂肪干细胞通过雌激素非依赖途径促进 ER⁺ 乳腺癌转移。
Int J Mol Sci. 2019 Mar 20;20(6):1419. doi: 10.3390/ijms20061419.
4
Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer.氧化还原悖论:一种治疗抵抗性癌症的新方法。
Antioxid Redox Signal. 2018 Nov 1;29(13):1237-1272. doi: 10.1089/ars.2017.7485. Epub 2018 Feb 21.
5
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.A-激酶锚定蛋白 BIG3 协调乳腺癌细胞中的雌激素信号转导。
Nat Commun. 2017 May 30;8:15427. doi: 10.1038/ncomms15427.
6
Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.蛋白激酶C介导的药物转运体活性、定位及表达调控
Int J Mol Sci. 2017 Apr 4;18(4):764. doi: 10.3390/ijms18040764.
7
Cancer drug resistance: redox resetting renders a way.癌症耐药性:氧化还原重设提供了一种方法。
Oncotarget. 2016 Jul 5;7(27):42740-42761. doi: 10.18632/oncotarget.8600.
8
Reversal of efflux of an anticancer drug in human drug-resistant breast cancer cells by inhibition of protein kinase Cα (PKCα) activity.通过抑制蛋白激酶Cα(PKCα)活性逆转人耐药乳腺癌细胞中抗癌药物的外排
Tumour Biol. 2016 Feb;37(2):1901-8. doi: 10.1007/s13277-015-3963-4. Epub 2015 Sep 2.
9
Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration.揭示新型内质网蛋白 KIAA1199 在癌细胞迁移中的作用。
J Natl Cancer Inst. 2013 Sep 18;105(18):1402-16. doi: 10.1093/jnci/djt224. Epub 2013 Aug 29.
10
Plasma RANTES, IL-10, and IL-8 levels in non-small-cell lung cancer patients treated with EGFR-TKIs.接受表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs)治疗的非小细胞肺癌患者的血浆调节激活正常T细胞表达和分泌因子(RANTES)、白细胞介素-10(IL-10)及白细胞介素-8(IL-8)水平
BMC Res Notes. 2013 Apr 8;6:139. doi: 10.1186/1756-0500-6-139.